Close
Help
Need Help?



Immunotherapy Insights


12,131 Journal Article Views

 


Is this journal right for my paper?

Ask Editor in Chief
Submit a Paper

Editor in Chief: John Barrett

Aims & Scope: Immunotherapy Insights is an open access, peer reviewed journal which covers all aspects of manipul... more

Indexing: CAB Abstracts, CABI Global Health, Chemical Abstracts Service, Chinese Electronic Periodical Service, EBSCO CINAHL Complete, Gale Academic OneFile, Gale Health Reference Centre, Gale InfoTrac Custom Journals, Index Copernicus, OAlster, ProQuest Health & Medical Complete, Socolar

Directories: Academic Journals Database, EBSCO A-Z, HINARI, JournalSeek, JournalTOCs, OAJSE, Scirus, Ulrich's Periodicals

Processing Speed: Editorial decision less than 3 weeks, publication in average 3 weeks after acceptance

ISSN: 1179-1756



Signup for Email Alerts and keep in touch with Immunotherapy Insights journal news, updates, events and articles

Article Search

Items per page:

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
testimonial_image
This is my first experience working with the journal and it has been the easiest publication process that I can imagine. The links sent make login simple. The revisions are made so quickly. The decisions are made rapidly. We will definitely be working with this journal again.
Dr Chris Bushe (Senior Clinical Research Physician, Lilly, Basingstoke, Hampshire, UK)
More Testimonials

Quick Links

Follow Us We make it easy to find new research papers.
Email AlertsRSS Feeds
FacebookGoogle+Twitter
PinterestTumblrYouTube

SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results